scPharmaceuticals, Inc.

scPharmaceuticals, Inc.

scPharmaceuticals, Inc.

Overview
Headquarters

2400 District Avenue, Suite 310, Burlington, MA, 01830, USA

Type of Company

Public

Employees (Worldwide)

17

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services

Company Description

scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Contact Data
Trying to get in touch with decision makers at scPharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Chief Financial Officer & Director

Chief Accounting Officer & Senior Vice President-Finance

Director-IR & Corporate Development

Director

Senior Vice President-Technical Operations

Vice President, Pharmaceutical Development

Other Contacts

Board of Directors

Founder at Supernus Pharmaceuticals, Inc.

Principal at North Bristol Partners LLC

Former Partner at KPMG LLP

Venture Partner at OrbiMed Advisors LLC

Chief Financial Officer & Principal Accounting Officer at Insmed, Inc.

Regulatory Practice at YourEncore, Inc.

Chief Executive Officer at Lundbeckfonden Ventures

President, Chief Executive Officer, Chief Financial Officer & Director at scPharmaceuticals, Inc.

Paths to scPharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
scPharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Ikarian Capital LLC is an American private company headquartered in Dallas, TX, that operates in several countries and provides investment advice. The firm was founded by Neil Tristan Shahrestani. Ikarian Capital LLC controls a large interest in TRACON Pharmaceuticals, Inc. (32.88 %).

Details Hidden

Worth Venture Partners LLC is a private company headquartered in New York, NY, with a presence in the United States, that provides investment advice. It was founded in 2012. Abby I. Flamholz and David Alexander Wertentheil are the current co-CEOs of the firm.

Recent Transactions
Details Hidden

scPharmaceuticals, Inc. issued . USD Common Stock

Details Hidden

scPharmaceuticals, Inc. issued USD Common Stock

Details Hidden

scPharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Underwriter

Advised onscPharmaceuticals, Inc. issued USD Common Stock

Escrow Agent

Advised onscPharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onscPharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onscPharmaceuticals, Inc. issued USD Common Stock

Associate

Advised onscPharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onscPharmaceuticals, Inc. issued . USD Common Stock

Advisors & Consultants
Publicist

Managing Director at Westwicke Partners LLC

Key Stats and Financials As of 2019
Market Capitalization
$175M
Total Enterprise Value
$52.9M
Earnings Per Share
$-1.77
Net Profit
$-33M
EBITDA
$-32.5M
Total Debt
$20.3M
Total Equity
$51.4M
TEVNet Income
-1.6x
Debt TEV
0.38x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Revenue
$0
Investors
Details Hidden

Orbimed Advisors Private Equity seeks investment opportunities in private and public healthcare companies located in globally primarily North America, Asia, Europe and Israel. The firm targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage capital for large publicly traded companies.

Details Hidden

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Details Hidden

5AM Ventures invests in next-generation life sciences companies located in the US. The firm targets companies operating in the fields of biopharmaceutical, drug delivery technologies and research instruments. They provides financing for early stage and corporate spin-out capital requirements with an investment size ranging from $20 to $30 million and also makes co-investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by scPharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of scPharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and scPharmaceuticals, Inc..